Cargando…
Bi-Functional Radiotheranostics of (188)Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells
Epidermal growth factor receptor (EGFR) specific therapeutics is of great importance in cancer treatment. Fcy-hEGF fusion protein, composed of yeast cytosine deaminase (Fcy) and human EGF (hEGF), is capable of binding to EGFR and enzymatically convert 5-fluorocytosine (5-FC) to 1000-fold toxic 5-flu...
Autores principales: | Huang, Yi-Shu, Hsu, Wei-Chuan, Lin, Chien-Hong, Lo, Sheng-Nan, Cheng, Chu-Nian, Lin, Ming-Syuan, Lee, Te-Wei, Chang, Chih-Hsien, Lan, Keng-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918434/ https://www.ncbi.nlm.nih.gov/pubmed/33672989 http://dx.doi.org/10.3390/ijms22041902 |
Ejemplares similares
-
Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021) -
Molecular Pharming of the Recombinant Protein hEGF-hEGF Concatenated with Oleosin Using Transgenic Arabidopsis
por: Qiang, Weidong, et al.
Publicado: (2020) -
Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib
por: He, Peng, et al.
Publicado: (2013) -
Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
por: Sweetenham, J. W., et al.
Publicado: (1990) -
Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan.
por: Robinson, B. A., et al.
Publicado: (1985)